The total return over the past 12 months is +104.00% vs. +15.54% for the S&P 500. So far it's up +51.19% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +104.00% | +13.04% | (18.18%) | +8.02% | +20.75% | +15.42% |
| Total Return CAGR | +104.00% | +13.04% | (18.18%) | +8.10% | +20.81% | +15.46% |
| Revenue CAGR | +11.19% | +11.58% | +9.41% | +15.90% | +22.45% | +29.40% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +56.94% | N/A | +24.64% | +2.89% | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
NeoGenomics, Inc. (NEO)
| Year | Start price | End price | NEO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $11.76 | $17.78 | +51.19% | +12.91% | +38.28% |
| 2025 | $16.48 | $11.76 | (28.64%) | +17.72% | (46.36%) |
| 2024 | $16.18 | $16.48 | +1.85% | +24.89% | (23.04%) |
| 2023 | $9.24 | $16.18 | +75.11% | +26.19% | +48.92% |
| 2022 | $34.12 | $9.24 | (72.92%) | (18.17%) | (54.75%) |
| 2021 | $53.84 | $34.12 | (36.63%) | +28.74% | (65.37%) |
| 2020 | $29.25 | $53.84 | +85.44% | +18.37% | +67.07% |
| 2019 | $12.61 | $29.25 | +131.96% | +31.22% | +100.74% |
| 2018 | $8.86 | $12.61 | +42.33% | (4.56%) | +46.89% |
| 2017 | $8.57 | $8.86 | +3.38% | +21.70% | (18.32%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
